• SFTSV NSs Disrupt DPP9 Complex to Activate NLRP1/CARD8 Infla

  2026-05-20

  Liu et al. reveal a novel mechanism by which the SFTSV non-structural protein (NSs) activates NLRP1 and CARD8 inflammasomes through disruption of the DPP9-mediated inhibitory complex. This discovery advances our understanding of innate immune regulation and highlights new intervention strategies for pathogen sensing and inflammasome modulation.

• Scenario-Driven mRNA Purification with Oligo (dT) 25 Beads

  2026-05-19

  This article explores scenario-based laboratory challenges in eukaryotic mRNA isolation and demonstrates how Oligo (dT) 25 Beads (SKU K1306) provide robust, reproducible solutions. Grounded in validated workflows and peer-reviewed literature, it addresses practical pain points for biomedical researchers and guides optimal use of magnetic bead-based mRNA purification.

• Tobramycin: Applied Protocols for Gram-Negative Bacterial Re

  2026-05-19

  Tobramycin, a water-soluble aminoglycoside antibiotic, is the gold standard for reproducible Gram-negative bacterial assays and antibiotic resistance studies. This guide delivers actionable workflows, troubleshooting insights, and evidence-based parameterization to maximize research outcomes using Tobramycin from APExBIO.

• Tunable Human Intestinal Organoids: Balancing Renewal and Di

  2026-05-18

  Yang et al. present a robust, tunable culture system for human intestinal organoids that achieves a controlled balance between adult stem cell self-renewal and differentiation. By leveraging combinations of small molecule pathway modulators, the study significantly advances the scalability and cellular diversity of organoid models, enabling new opportunities for high-throughput research and disease modeling.

• Cy5 NHS ester(Et): Technical Guide for Protein Labeling Work

  2026-05-18

  Cy5 NHS ester(Et) is a high-purity, water-soluble fluorescent dye for labeling primary amines in proteins, peptides, and related biomolecules. It is optimized for workflows such as immunofluorescence staining, flow cytometry, and fluorescence microscopy where immediate-use, robust labeling is required. This reagent is not suitable for ethanol-based protocols or long-term storage of working dye solutions.

• A High-Throughput Surrogate Model for BBB Permeability Predi

  2026-05-17

  This study introduces a robust, high-throughput in vitro model based on LLC-PK1-MOCK/MDR1 cells for accurate blood-brain barrier (BBB) permeability prediction. By integrating lysosomal trapping correction, the model enhances CNS drug screening reliability and streamlines early-stage candidate prioritization.

• 4-Ethylphenyl Sulfate in Gut-Brain and Renal Biomarker Assay

  2026-05-16

  4-Ethylphenyl sulfate enables robust modeling of gut microbiota-brain interactions and quantitative assessment of renal dysfunction. APExBIO’s high-purity compound supports advanced workflows, bridging behavioral, neurological, and biomarker research with reproducible results.

• Trypsin’s Mechanistic Edge: Guiding Translational Breakthrou

  2026-05-15

  This thought-leadership article explores how trypsin, a serine protease best known for its precision hydrolysis of lysine and arginine, is redefining translational research workflows beyond classic protein digestion. Integrating mechanistic insight with actionable strategy, we bridge emerging findings in genome stability, cell proliferation, and viral fusion, highlighting APExBIO's BA5744 Trypsin and best practices for protocol optimization. Drawing on the latest R-loop/DNA damage literature and advanced application guides, this piece uniquely positions trypsin as a cornerstone for reproducible, high-impact discovery.

• Thrombin B Chain Fragment: Precision Tools for Fibrin Matrix

  2026-05-15

  Explore the advanced role of thrombin, a trypsin-like serine protease, in fibrin matrix modeling and angiogenesis. This article delivers a rigorous, protocol-driven analysis of Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens]—with unique insights for vascular and tumor microenvironment research.

• Calpain Inhibitor I, ALLN: Protocol and Troubleshooting Guid

  2026-05-14

  Calpain Inhibitor I, ALLN is a potent, selective inhibitor for calpain and cathepsin proteases, providing researchers with a reliable tool for apoptosis assays, inflammation studies, and ischemia-reperfusion injury models. Its use is best suited to mechanistic studies requiring high specificity, but it is not intended for diagnostic or clinical applications.

• Surrogate BBB Model Enables High-Throughput CNS Drug Screeni

  2026-05-14

  This study introduces a high-throughput in vitro blood-brain barrier (BBB) model that integrates LLC-PK1-MOCK/MDR1 cells with lysosomal trapping correction, improving the prediction of CNS drug permeability. The model demonstrates strong in vitro–in vivo correlation and addresses key transport mechanisms, streamlining early-stage CNS drug discovery.

• AM251: Potent CB1 Receptor Antagonist for Neuroscience Resea

  2026-05-13

  AM251 is a highly selective CB1 receptor antagonist with nanomolar affinity. It is used to dissect endocannabinoid signaling, modulate neurotransmitter release, and model metabolic and cell cycle effects in vitro and in vivo.

• Oligo (dT) 25 Beads: Optimized Workflow for mRNA Purificatio

  2026-05-13

  Oligo (dT) 25 Beads enable rapid and efficient isolation of eukaryotic mRNA from total RNA or lysates, supporting high-quality downstream molecular biology applications. This product is best suited for workflows requiring reliable polyA tail mRNA capture; it is not intended for prokaryotic RNA or samples lacking polyadenylation.

• Gemcitabine HCl: Protocol Innovations for Pancreatic Tumor M

  2026-05-12

  Gemcitabine HCl powers high-throughput, quantitative tumor monitoring in preclinical pancreatic cancer research. Discover protocol enhancements, advanced MRI-guided workflows, and troubleshooting strategies that maximize the translational impact of DNA replication inhibition and apoptosis assays using APExBIO’s proven reagent.

• (R,S)-Anatabine: Amyloid Pathway Inhibition in Alzheimer's M

  2026-05-12

  (R,S)-Anatabine is a minor tobacco alkaloid and amyloid precursor protein β-cleavage inhibitor. It reduces soluble Aβ peptide levels and modulates BACE-1 and NF-κB pathways, with confirmed activity in both in vitro and in vivo Alzheimer's disease models. APExBIO supplies (R,S)-Anatabine as a high-purity solution for neurodegeneration research applications.

16254 records 1/1084 page Next 12345 下5页 Last page